You-Take Oh
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- Lung Cancer Research Studies
-
- Cell death mechanisms and regulation
- Cancer therapeutics and mechanisms
- PI3K/AKT/mTOR signaling in cancer
- Ubiquitin and proteasome pathways
Papers in
-
- Cell death mechanisms and regulation 14
- Melanoma and MAPK Pathways 4
- PI3K/AKT/mTOR signaling in cancer 3
- Ubiquitin and proteasome pathways 3
- Oncology 11
- Cancer-related Molecular Pathways 6
- Cytokine Signaling Pathways and Interactions 2
- Co-authors
- Shi‐Yong Sun (17 shared papers)Ping Yue (10 shared papers)Taofeek K. Owonikoko (5 shared papers)Fadlo R. Khuri (6 shared papers)Suresh S. Ramalingam (5 shared papers)Puyu Shi (3 shared papers)Guojing Zhang (3 shared papers)Weilong Yao (4 shared papers)
- Journals
- Journal of Biological Chemistry (3 papers)APOPTOSIS (3 papers)Oncotarget (2 papers)Oncogene (2 papers)Cancer Research (2 papers)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
You-Take Oh
23 papers receiving 664 citations
Peers
Comparison fields: 5 of 64
- Oncology 251
- Molecular Biology 506
- Pulmonary and Respiratory Medicine 232
- Cancer Research 94
- Pharmacology 41
Countries citing papers authored by You-Take Oh
This map shows the geographic impact of You-Take Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by You-Take Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites You-Take Oh more than expected).
Fields of papers citing papers by You-Take Oh
This network shows the impact of papers produced by You-Take Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by You-Take Oh. The network helps show where You-Take Oh may publish in the future.
Co-authors
The 25 scholars most cited alongside You-Take Oh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 147 | |
| 2 | 2017 | 113 | |
| 3 | 2010 | 60 | |
| 4 | Effect of red ginseng on natural killer cell activity in mice with lung adenoma induced by urethan and benzo(a)pyrene. | 1987 | 38 |
| 5 | 2015 | 37 | |
| 6 | 2011 | 36 | |
| 7 | 2021 | 34 | |
| 8 | 2015 | 32 | |
| 9 | 2010 | 27 | |
| 10 | 2016 | 25 | |
| 11 | 2007 | 25 | |
| 12 | 2017 | 23 | |
| 13 | 2007 | 20 | |
| 14 | 2018 | 15 | |
| 15 | 2017 | 10 | |
| 16 | 2021 | 10 | |
| 17 | 2019 | 6 | |
| 18 | 2005 | 5 | |
| 19 | 2021 | 4 | |
| 20 | 2024 | 2 |
About You-Take Oh
You-Take Oh is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Pathology and Forensic Medicine, having authored 23 papers that have together received 672 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (14 papers), Cancer-related Molecular Pathways (6 papers), Melanoma and MAPK Pathways (4 papers), Lung Cancer Treatments and Mutations (4 papers), NF-κB Signaling Pathways (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Ubiquitin and proteasome pathways (3 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Oncology (251 citations), Molecular Biology (506 citations), Pulmonary and Respiratory Medicine (232 citations), Cancer Research (94 citations) and Pharmacology (41 citations). You-Take Oh has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Shi‐Yong Sun, Ping Yue, Taofeek K. Owonikoko, Fadlo R. Khuri, Suresh S. Ramalingam, Puyu Shi, Guojing Zhang, Weilong Yao, Jiusheng Deng and Guoqing Qian. Their work appears in journals such as Journal of Biological Chemistry, APOPTOSIS, Oncotarget, Oncogene and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.